All three primary cell surface receptors used for breast cancer subtyping (ER, PR, and HER2) were significantly associated with ANLN and KDR expression (Table 1), suggesting that the synergistic effect of ANLN and KDR can affect cells’ transition from the triple negative to the luminal-like phenotype. Here, CD177 is linked to breast cancer.